concept

DEFEROXAMINE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DEFEROXAMINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

22Connections

1Hypotheses

1Analyses

15Outgoing

7Incoming

0Experiments

1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DEFEROXAMINE
Related Diseases	AGING, APOPTOSIS, AUTOPHAGY, CHOLESTEROL, FERROPTOSIS

Pathway Diagram

graph TD
    DEFEROXAMINE[DEFEROXAMINE]
    DEFEROXAMINE -->|treats| LIPID_PEROXIDATION[LIPID PEROXIDATION]
    DEFEROXAMINE -->|inhibits| SENESCENCE[SENESCENCE]
    DEFEROXAMINE ---|associated| DEFERIPRONE[DEFERIPRONE]
    DEFEROXAMINE ---|associated| FERROPTOSIS[FERROPTOSIS]
    DEFEROXAMINE ---|associated| AUTOPHAGY[AUTOPHAGY]
    DEFEROXAMINE ---|associated| APOPTOSIS[APOPTOSIS]
    DEFEROXAMINE ---|associated| ROS[ROS]
    DEFEROXAMINE ---|associated| N_ACETYLCYSTEINE[N-ACETYLCYSTEINE]
    AGING[AGING] -->|inhibits| DEFEROXAMINE
    NEURODEGENERATION[NEURODEGENERATION] ---|associated| DEFEROXAMINE
    N_ACETYLCYSTEINE ---|associated| DEFEROXAMINE
    APOPTOSIS ---|associated| DEFEROXAMINE
    AUTOPHAGY ---|associated| DEFEROXAMINE
    LIPID_PEROXIDATION ---|associated| DEFEROXAMINE

Outgoing (15)

Target	Relation	Type	Str
h-5050522d	targeted_by	hypothesis	1.00
Erastin-induced ferroptosis	protects_against	mechanism	0.70
SENESCENCE	inhibits	phenotype	0.65
LIPID PEROXIDATION	treats	phenotype	0.65
DEFERIPRONE	associated_with	drug	0.45
SENESCENCE	associated_with	phenotype	0.45
AGING	associated_with	phenotype	0.45
INFLAMMATION	associated_with	phenotype	0.45
FERROPTOSIS	associated_with	phenotype	0.45
AUTOPHAGY	associated_with	phenotype	0.45
APOPTOSIS	associated_with	phenotype	0.45
ROS	associated_with	phenotype	0.45
N-ACETYLCYSTEINE	associated_with	drug	0.45
NAC	associated_with	drug	0.45
CHOLESTEROL	associated_with	phenotype	0.45

Incoming (7)

Source	Relation	Type	Str
h-5050522d	targets	hypothesis	1.00
AGING	inhibits	phenotype	0.65
NEURODEGENERATION	associated_with	phenotype	0.50
N-ACETYLCYSTEINE	associated_with	drug	0.45
APOPTOSIS	associated_with	phenotype	0.45
AUTOPHAGY	associated_with	phenotype	0.45
LIPID PEROXIDATION	associated_with	phenotype	0.45

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio	0.838	neurodegeneration	View

Mentioning Analyses (1)

Scientific analyses that reference this entity

What determines the GPX4/ACSL4 balance that switches microglia from protective t

immunology | 2026-04-15 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While ACSL4-driven ferroptosis was strongly supported, the molecular triggers th

closed · Rounds: 4 · Score: 0.80 · 2026-04-16

Related Research

Hypotheses and analyses mentioning DEFEROXAMINE in their description or question text

No additional research found